DAL vs FOLD
Delta Air Lines Inc (DAL) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the DAL and FOLD stock pages for the full models.
Not investment advice.